- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01925014
Low vs. Standard Dose CT for Appendicitis Trial (LOCAT)
August 21, 2018 updated by: Kyoung Ho Lee, MD
A Multi-institutional Trial Comparing Clinical Outcomes Following Low- vs. Standard-dose Abdominal CT as the First-line Imaging Test in Adolescents and Young Adults With Suspected Acute Appendicitis
To determine whether low-dose (LD) CT is noninferior to standard-dose (SD) computed tomography (CT) as the first-line imaging test in adolescents and young adults in regard to negative appendectomy rate (NAR).
Study Overview
Status
Completed
Conditions
Detailed Description
- Acute appendicitis is a very common disease. Many patients are adolescents or young adults.
- CT is the current standard imaging test for the diagnosis of appendicitis.
- In recent years, the awareness of carcinogenic risk associated with CT radiation has increased.
- According to a recent single-institutional randomized controlled trial, LD CT (employing a quarter of standard radiation dose) was found to be noninferior to SD CT with respect to NARs in adolescents and young adults with suspected appendicitis.
- However, LD CT is not yet widely accepted.
- To establish LD CT as the first-line imaging test, a multi-institutional study is needed to confirm the generalizability of the prior single-institutional study.
Study Type
Interventional
Enrollment (Actual)
3074
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Daegu, Korea, Republic of, 700-712
- Keimyung University Dongsan Medical Center
-
Gwangju, Korea, Republic of, 501-757
- Chonnam National University Hospital
-
Iksan, Korea, Republic of, 570-711
- Wonkwang University School of Medicine & Hospital
-
Incheon, Korea, Republic of, 405-760
- Gachon University Gil Medical Center
-
Jeju City, Korea, Republic of, 690-767
- Jeju National University Hospital
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
Seoul, Korea, Republic of, 156-755
- Chung-Ang University Hospital
-
Seoul, Korea, Republic of, 152-703
- Korea University Guro Hospital
-
Seoul, Korea, Republic of, 120-752
- Severance Hospital
-
Seoul, Korea, Republic of, 150-950
- Hallym University Kangnam Sacred Heart Hospital
-
Seoul, Korea, Republic of, 110-746
- Kangbuk Samsung Hospital
-
Seoul, Korea, Republic of, 137-701
- The Catholic University of Korea, College of Medicine, Seoul St. Mary's Hospital
-
Seoul, Korea, Republic of, 140-887
- Soonchunhyang University Seoul Hospital
-
-
Gangwon
-
Chuncheon, Gangwon, Korea, Republic of, 200-722
- Kangwon National University Hospital
-
-
Gyeonggi
-
Ansan, Gyeonggi, Korea, Republic of, 425-707
- Korea University Ansan Hospital
-
Anyang, Gyeonggi, Korea, Republic of, 431-070
- Hallym University Sacred Heart Hospital
-
Bucheon, Gyeonggi, Korea, Republic of, 420-767
- Soonchunhyang University Bucheon Hospital
-
Sanbon, Gyeonggi, Korea, Republic of, 435-040
- Wonkwang University Sanbon Hospital
-
Seongnam, Gyeonggi, Korea, Republic of, 463-707
- Seoul National University Bundang Hospital
-
Seongnam, Gyeonggi, Korea, Republic of, 463-774
- Daejin Medical Center, Bundang Jesaeng General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 44 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Emergency department visit with suspected symptoms and signs of acute appendicitis
- Intravenous contrast-enhanced computed tomography examination requested due to suspicion of appendicitis
- Willing to provide telephone or cell phone numbers for follow-up
- Signed informed consent provided prior to study entry
Exclusion Criteria:
- Prior cross-sectional imaging tests to evaluate the presenting symptoms and signs
- Prior history of surgical removal of the appendix
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Low-dose CT
Diagnostic CT with low-dose radiation
|
Effective dose is aimed at approximately 2 millisievert (mSv) in an average patient.
Other Names:
|
ACTIVE_COMPARATOR: Standard-dose CT
Diagnostic CT with standard-dose radiation
|
Effective dose is aimed at approximately 8 millisievert (or less) in an average patient.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Negative Appendectomy Rate
Time Frame: 1 week after surgery
|
Negative appendectomy rate was defined as the percentage of negative (unnecessary) appendectomies among all non-incidental appendectomies.
As a secondary analysis, negative appendectomy rate in an alternative definition was calculated by excluding cases with appendiceal neoplasms without superimposed appendicitis, as appendectomy would be clinically necessary in such patients.
Any surgery performed for the treatment of presumed appendicitis was counted as non-incidental appendectomy, even though the surgical procedures were more extensive than simple appendectomy (e.g., ileocectomy).
|
1 week after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Appendiceal Perforation Rate
Time Frame: 1 week after surgery
|
The percentage of perforated appendicitis among confirmed appendicitis cases.
|
1 week after surgery
|
Number of Appendectomies
Time Frame: 3 months after CT
|
Appendectomy rate.
The percentage of appendectomies among all randomized cases.
|
3 months after CT
|
Number of Negative Appendectomies
Time Frame: 1 week after surgery
|
The percentage of negative appendectomies among all randomized cases.
In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies.
Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.
|
1 week after surgery
|
Prevalence of Perforated Appendicitis
Time Frame: 1 week after surgery
|
The percentage (i.e., prevalence) of perforated appendicitis among all randomized cases.
In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies.
Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.
|
1 week after surgery
|
Prevalence of Non-perforated Appendicitis
Time Frame: 1 week after surgery
|
The percentage (i.e., prevalence) of non-perforated appendicitis among all randomized cases.
In January, 2016, when more than 2000 patients were enrolled, the data and safety monitoring board noted a between-group imbalance in the number of appendectomies.
Because of the concern that such an imbalance might potentially jeopardize the comparability for the prespecified endpoints, the study protocol was amended to adopt the following additional secondary endpoints, which were assessed among all randomly assigned patients: the number of appendectomies, number of negative appendectomies, prevalence of perforated appendicitis, and prevalence of non-perforated appendicitis.
|
1 week after surgery
|
Need for Additional Imaging Test(s)
Time Frame: 1 week after CT
|
The proportion of patients requiring additional imaging test(s) in order to diagnose or rule out appendicitis.
|
1 week after CT
|
Delay in Patient Disposition
Time Frame: 3 months after CT
|
|
3 months after CT
|
Length of Hospital Stay Associated With Appendectomy
Time Frame: 3 months after CT
|
The interval from CT acquisition to hospital discharge after appendectomy.
|
3 months after CT
|
Diagnostic Performance of CT Reports - AUC
Time Frame: 3 months after CT
|
- Area under the receiver-operating-characteristic curve (AUC).
|
3 months after CT
|
Diagnostic Performance of CT Reports - Sensitivity and Specificity
Time Frame: 3 months after CT
|
|
3 months after CT
|
Diagnostic Confidence in Diagnosing and Ruling Out Appendicitis: Likelihood Score for Appendicitis
Time Frame: 3 months after CT
|
Grade 1 denotes appendicitis definitely absent; grade 2, appendicitis probably absent; grade 3, indeterminate for the presence of appendicitis; grade 4, appendicitis probably present; and grade 5, appendicitis definitely present. |
3 months after CT
|
Diagnostic Confidence in Diagnosing and Ruling Out Appendicitis: Indeterminate Interpretation (Grade 3)
Time Frame: 3 months after CT
|
The frequency of indeterminate CT interpretation (grade 3).
Grade 1 denotes appendicitis definitely absent; grade 2, appendicitis probably absent; grade 3, indeterminate for the presence of appendicitis; grade 4, appendicitis probably present; and grade 5, appendicitis definitely present.
|
3 months after CT
|
Diagnostic Confidence in Ruling Out Appendicitis: Normal Appendix Visualization
Time Frame: 3 months after CT
|
The frequency of normal appendix visualization at CT. Grade 0 denotes appendix not identified; grade 1, unsure or partly visualized; and grade 2, clearly and entirely visualized.
|
3 months after CT
|
Diagnosis of Appendiceal Perforation at CT
Time Frame: 3 months after CT
|
|
3 months after CT
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Chair: Kyoung Ho Lee, MD, Seoul National University Bundang Hospital
- Study Director: Kyuseok Kim, MD, Seoul National University Bundang Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kim K, Kim YH, Kim SY, Kim S, Lee YJ, Kim KP, Lee HS, Ahn S, Kim T, Hwang SS, Song KJ, Kang SB, Kim DW, Park SH, Lee KH. Low-dose abdominal CT for evaluating suspected appendicitis. N Engl J Med. 2012 Apr 26;366(17):1596-605. doi: 10.1056/NEJMoa1110734.
- Ahn S; LOCAT group. LOCAT (low-dose computed tomography for appendicitis trial) comparing clinical outcomes following low- vs standard-dose computed tomography as the first-line imaging test in adolescents and young adults with suspected acute appendicitis: study protocol for a randomized controlled trial. Trials. 2014 Jan 17;15:28. doi: 10.1186/1745-6215-15-28.
- Ko Y, Choi JW, Kim DH, Lee KJ, Shin SS, Woo JY, Cho SW, Kim BS, Lee KH. Central image archiving and management system for multicenter clinical studies: lessons from low-dose CT for appendicitis trial. J Korean Soc Radiol. 2017 Mar 28;76(3):165-72. doi: 10.3348/jksr.2017.76.3.165.
- Yang HK, Ko Y, Lee MH, Woo H, Ahn S, Kim B, Pickhardt PJ, Kim MS, Park SB, Lee KH; Low-Dose CT for Appendicitis Trial (LOCAT) Group. Initial Performance of Radiologists and Radiology Residents in Interpreting Low-Dose (2-mSv) Appendiceal CT. AJR Am J Roentgenol. 2015 Dec;205(6):W594-611. doi: 10.2214/AJR.15.14513. Erratum In: AJR Am J Roentgenol. 2016 Apr;206(4):901. multiple investigator names added.
- Kim HY, Lee S, Kim DH, Ko Y, Park JH, Ko A, Jeong SM, Park SB, Lee KH; LOCAT Group. Conventional-Dose CT Versus 2-mSv CT for Right Colonic Diverticulitis as an Alternate Diagnosis of Appendicitis: Secondary Analysis of Large Pragmatic Randomized Trial Data. AJR Am J Roentgenol. 2021 Nov;217(5):1113-1121. doi: 10.2214/AJR.21.25584. Epub 2021 Apr 7.
- LOCAT Group. Low-dose CT for the diagnosis of appendicitis in adolescents and young adults (LOCAT): a pragmatic, multicentre, randomised controlled non-inferiority trial. Lancet Gastroenterol Hepatol. 2017 Nov;2(11):793-804. doi: 10.1016/S2468-1253(17)30247-9. Epub 2017 Sep 12.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 1, 2013
Primary Completion (ACTUAL)
December 1, 2016
Study Completion (ACTUAL)
February 1, 2017
Study Registration Dates
First Submitted
August 15, 2013
First Submitted That Met QC Criteria
August 16, 2013
First Posted (ESTIMATE)
August 19, 2013
Study Record Updates
Last Update Posted (ACTUAL)
January 31, 2019
Last Update Submitted That Met QC Criteria
August 21, 2018
Last Verified
August 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- LOCAT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The LOCAT Group has an active standpoint for sharing the LOCAT data, which is in line with the proposal from the International Committee of Medical Journal Editors.
The LOCAT Group will share de-identified individual-participant data underlying the main LOCAT results no later than 6 months after the publication of the results.
The data will be kept in a publicly available website and freely available to anyone upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Appendicitis
-
North Estonia Medical CentreTartu University HospitalRecruitingAcute Appendicitis | Appendicitis Acute | Appendicitis Perforated | Acute Appendicitis With Rupture | Appendicitis; Perforation | Acute Appendicitis Without Peritonitis | Acute Appendicitis With Appendix AbscessEstonia
-
University of MichiganCompletedAppendicitis | Complicated Appendicitis | Perforated Appendicitis | Ruptured AppendicitisUnited States
-
HJ23Hospital Universitari Joan XXIII de Tarragona.Not yet recruitingAcute Appendicitis | Appendicitis Perforated | Appendicitis Suppurative
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedAppendicitis | Appendicitis Acute | Appendiceal Abscess | Appendicolith | Appendicitis With Perforation | Appendicitis PeritonitisItaly
-
Johns Hopkins All Children's HospitalCompleted
-
Pirogov Russian National Research Medical UniversityCompletedAcute Appendicitis | Acute Appendicitis With Rupture | Acute Appendicitis Without Peritonitis | Acute Appendicitis With PeritonitisRussian Federation
-
Phoenix Children's HospitalTerminatedComplicated Appendicitis | Perforated AppendicitisUnited States
-
Faculty Hospital Kralovske VinohradyCompletedAppendicitis | Appendicitis Acute | Retrocecal AppendicitisCzechia
-
King Abdulaziz UniversityCompletedAppendicitis | Acute Appendicitis | Pathology | Appendicitis (Diagnosis)Saudi Arabia
-
Mauro PoddaAssociazione Chirurghi Ospedalieri ItalianiCompletedAcute Appendicitis | Appendectomy | Antibiotic Therapy | Appendicitis RecurrentItaly
Clinical Trials on Diagnostic CT with low-dose radiation
-
Seoul National University Bundang HospitalGE Healthcare; National Research Foundation of KoreaCompletedAppendicitisKorea, Republic of
-
University of CincinnatiNational Cancer Institute (NCI); Ohio Third FrontierActive, not recruitingPET/CT ImagingUnited States
-
Seoul St. Mary's HospitalGE HealthcareNot yet recruitingAppendicitis Acute
-
Seoul National University HospitalCompletedHepatocellular CarcinomaKorea, Republic of
-
The Netherlands Cancer InstituteCompleted
-
Fundació Institut de Recerca de l'Hospital de la...Sociedad Española de Neumología y Cirugía TorácicaNot yet recruitingLung Cancer | Protection Against Malignant Lung Neoplasm (Diagnosis)
-
Emory UniversityNational Cancer Institute (NCI)TerminatedPneumonia | Coronavirus Infection in 2019 (COVID-19) | Severe Acute Respiratory Syndrome (SARS) PneumoniaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Mantle Cell Lymphoma | Refractory Mantle Cell LymphomaUnited States
-
Intermed HospitalNot yet recruiting
-
Yale UniversityAgency for Healthcare Research and Quality (AHRQ)Completed